Review of the Diagnosis and Treatment of Pregnant Psychiatric Inpatients

References (4)

1. Cetin M. Psychotropic drug use in pregnancy: an update. Bulletin of Clinical Psychopharmacology 2011; 21:161-173. (Turkish) [CrossRef] Koren G, Boucher N. Adverse effects in neonates exposed to SSRIs and SNRI in late gestation. Can J Clin Pharmacol 2009; 16:66-67.
2. Louik C, Lin AE, Werler MM, Hernanz Diaz S, Mitchell AA. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007; 356:2675-2683. [CrossRef] Oguzhanoglu NK, Varma GS. The course of psychiatric disorders during pregnancy. Last Word in Psychiatry 2013; 3:276-287. (Turkish) Hou Y, Hu P, Zhang Y, Lu Q, Wang D, Yin L, Chen Y, Zou X. Cognitive behavioral therapy in combination with systemic family therapy improves mild to moderate postpartum depression. Rev Bras Psiquiatr 2014; 36:47-52. [CrossRef] Anderson EL, Reti IM. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med 2009; 71:235-242. [CrossRef] Yonkers KA, Vigod S, Ross LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol 2011; 117:961-977. [CrossRef] Alpay N, Karsidag C. Electroconvulsive therapy in pregnancy: a review. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2006; 19:204-211. (Turkish) Kohen D. Psychotropic medication in pregnancy. Adv Psychiatr Treat 2003; 10:59-66. [CrossRef] Yeshayahu Y. The use of olanzapine in pregnancy and congenital cardiac and musculoskeletal abnormalities. Am J Psychiatry 2007; 164:1759-1760. [CrossRef] Einarson A. Risks / safety of psychotropic medication use during pregnancy. Can J Clin Pharmacol 2009; 16:58-65.
3. Yacobi S, Ornoy A. Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. Isr J Psychiatry Relat Sci 2008; 45:95-106.
4. Alsdorf R, Wyszynski DF. Teratogenicity of sodium valproate. Expert Opin Drug Saf 2005; 4:345-53. [CrossRef]